“Appendix 3Y Change of Director’s Interest Notice” is posted.
View and download “Appendix 3Y Change of Director’s Interest Notice“.
The Stock Network Interview – How MagSense® is moving towards Phase 2 clinical trials
September 4, 2026
Lel Smits from The Stock Network sat down with Imagion Biosystems’ Bob Proulx to discuss how the company is moving through the critical steps required